U.S. Markets close in 2 hrs 59 mins

Misonix, Inc. (MSON)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
10.30-0.15 (-1.44%)
As of 12:21PM EDT. Market open.
People also watch

Misonix, Inc.

1938 New Highway
Farmingdale, NY 11735
United States

IndustryMedical Appliances & Equipment
Full Time Employees92

Key Executives

Mr. Stavros George Vizirgianakis B.Com.Pres, CEO & Director314.02kN/A47
Mr. Joseph P. DwyerChief Financial Officer285kN/A61
Mr. Robert Scott LudeckerSr. VP of Global Sales & Marketing385.62kN/A50
Mr. Richard A. ZarembaSr. VP of Fin., Sec. & Treasurer254.9k21.24k62
Mr. Dan VoicVP of R&D and Engineering223.14kN/A55
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company offers BoneScalpel, an ultrasonic bone cutting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various applications, such as spine, neuro, orthopedic, cosmetic, and laparoscopic surgeries, as well as in wound debridement, and other surgical and medical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Corporate Governance

Misonix, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.